MAIA Biotechnology Inc. (MAIA) — Financial Flexibility Index
Latest as of March 2026:
-0.70x
MAIA Biotechnology Inc. (MAIA) has a Financial Flexibility Index of -0.70x as of March 2026. Free cash flow of $-5.31 Million (operating CF $-5.31 Million minus capex $0.00) represents -1% of total liabilities ($7.56 Million).
Financial Flexibility Index
-0.70x
Free Cash Flow / Total Liabilities
Free Cash Flow
$-5.31 Million
Operating CF − Capex
Total Liabilities
$7.56 Million
USD
Capital Expenditures
$0.00
USD
MAIA Biotechnology Inc. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for MAIA Biotechnology Inc. across 7 annual periods. See MAIA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for MAIA Biotechnology Inc. (2019–2025)
Year-by-year free cash flow to debt coverage for MAIA Biotechnology Inc.. For the full company profile including market capitalisation, see MAIA market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.57x | $-18.84 Million | $-18.84 Million | $7.33 Million | ▼ -6.8% |
| 2024 | -2.41x | $-15.70 Million | $-15.70 Million | $6.52 Million | ▼ -30.6% |
| 2023 | -1.84x | $-13.07 Million | $-13.07 Million | $7.09 Million | ▲ +46.4% |
| 2022 | -3.44x | $-12.10 Million | $-12.10 Million | $3.51 Million | ▼ -79.2% |
| 2021 | -1.92x | $-4.12 Million | $-4.12 Million | $2.15 Million | ▼ -146.2% |
| 2020 | -0.78x | $-1.84 Million | $-1.84 Million | $2.36 Million | ▲ +79.6% |
| 2019 | -3.82x | $-1.57 Million | $-1.57 Million | $409.74K | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities